Bank of New York Mellon’s Poseida Therapeutics, Inc. Common Stock PSTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-201,957
| Closed | -$1.94M | – | 4182 |
|
|
2024
Q4 | $1.94M | Buy |
201,957
+37,856
| +23% | +$363K | ﹤0.01% | 2761 |
|
|
2024
Q3 | $469K | Sell |
164,101
-64,599
| -28% | -$185K | ﹤0.01% | 3549 |
|
|
2024
Q2 | $668K | Buy |
228,700
+26,316
| +13% | +$76.8K | ﹤0.01% | 3405 |
|
|
2024
Q1 | $646K | Sell |
202,384
-27,576
| -12% | -$88K | ﹤0.01% | 3370 |
|
|
2023
Q4 | $773K | Buy |
229,960
+18,663
| +9% | +$62.7K | ﹤0.01% | 3323 |
|
|
2023
Q3 | $503K | Sell |
211,297
-436
| -0.2% | -$1.04K | ﹤0.01% | 3537 |
|
|
2023
Q2 | $373K | Buy |
211,733
+162,950
| +334% | +$287K | ﹤0.01% | 3733 |
|
|
2023
Q1 | $150K | Hold |
48,783
| – | – | ﹤0.01% | 3998 |
|
|
2022
Q4 | $259K | Sell |
48,783
-685
| -1% | -$3.63K | ﹤0.01% | 3859 |
|
|
2022
Q3 | $175K | Buy |
49,468
+31,910
| +182% | +$113K | ﹤0.01% | 4062 |
|
|
2022
Q2 | $45K | Sell |
17,558
-84,491
| -83% | -$217K | ﹤0.01% | 4366 |
|
|
2022
Q1 | $457K | Sell |
102,049
-1,790
| -2% | -$8.02K | ﹤0.01% | 3759 |
|
|
2021
Q4 | $707K | Buy |
103,839
+2,451
| +2% | +$16.7K | ﹤0.01% | 3583 |
|
|
2021
Q3 | $739K | Buy |
101,388
+18,488
| +22% | +$135K | ﹤0.01% | 3575 |
|
|
2021
Q2 | $830K | Buy |
82,900
+19,800
| +31% | +$198K | ﹤0.01% | 3526 |
|
|
2021
Q1 | $603K | Buy |
63,100
+33,519
| +113% | +$320K | ﹤0.01% | 3584 |
|
|
2020
Q4 | $324K | Buy |
29,581
+6,289
| +27% | +$68.9K | ﹤0.01% | 3793 |
|
|
2020
Q3 | $206K | Buy |
+23,292
| New | +$206K | ﹤0.01% | 3841 |
|